PR Newswire
28 Mar 2023, 07:13 GMT+10
SYDNEY, March 28, 2023 /PRNewswire/ -- HaemaLogiX Ltd, a clinical stage biotech company developing novel immunotherapies for multiple myeloma, today announced that its anti-KMA CAR-T cell preclinical development has been completed and is the subject of an abstract accepted for poster presentation at the 2023 Annual Meeting of the American Association for Cancer Research (AACR), held 14-19 April in Orange County.
HaemaLogiX's CAR-T is being developed to target Kappa Myeloma Antigen (KMA) a myeloma-specific antigen not found on normal cells. The completed preclinical data demonstrates strong proof of concept to support the use of anti-KMA CAR-T cell therapy for the treatment of patients with myeloma.
The preclinical development of anti-KMA CAR-T forms part of a research collaboration project with the Centre of Excellence in Cellular Immunotherapy at the Peter MacCallum Cancer Centre.
The abstract is available here and the Poster will be made available by AACR and via the HaemaLogiX website shortly after presentation.
POSTER PRESENTATION DETAILS
Title: Cellular immunotherapy targeting kappa myeloma antigen for the treatment of multiple myeloma.
Presenter: HaemaLogiX Chief Scientific Officer Rosanne Dunn
Abstract ID: 4074 / 26
For more information, please contact:
Investors and Partners Bryce Carmine, Chairman and CEO HaemaLogiX Pty Ltd +61 481 344 140 | Media Jane Lowe, Managing Director IR Department +61 411 117 774 |
About HaemaLogiX Ltd - www.haemalogix.com:
Formed in 2014, HaemaLogiX is a public unlisted biotech company researching antibody therapies for multiple myeloma. Multiple myeloma is a haematological (blood) cancer of plasma cells (B cells) that can cause focused damage to a patient's bone marrow. Multiple myeloma is considered treatable but generally incurable. The HaemaLogiX team has a wide range and depth of experience in antibody research, nonclinical & clinical development, manufacturing and commercialisation. The Scientific Advisory Board (SAB) members are internationally recognised experts in monoclonal antibody therapies and haematology. Our current research and clinical trial partners are global leaders in Multiple Myeloma and AL Amyloidosis therapy. HaemaLogiX is located in Sydney, Australia
Get a daily dose of Asia Pacific Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Asia Pacific Star.
More InformationTensions between the long-time allies are not solely over tariffs and could have security implications, according to the outlet Relations...
New Delhi [India], July 14 (ANI): President Droupadi Murmu, graced the fifth convocation ceremony of AIIMS, Bhubaneswar, at Bhubaneswar,...
Dubai [UAE], July 14 (ANI): Madhya Pradesh Chief Minister Mohan Yadav, currently on an official visit to the UAE as part of the MP...
Dubai [UAE], July 14 (ANI): Madhya Pradesh Chief Minister Dr Mohan Yadav met industry leaders in the UAE's trade sector during his...
(250714) -- SHENZHEN, July 14, 2025 (Xinhua) -- Tanaka Kokoro (R) of Japan competes during the Group B match between Japan and the...
New Delhi [India], July 14 (ANI): Minister of State for External Affairs Pabitra Margherita, during his recent Malaysia visit, emphasised...
NEW YORK CITY, New York: Bitcoin surged to a new all-time high this week, buoyed by growing institutional interest and a wave of pro-crypto...
SHENZHEN, China: As global chip competition intensifies, Huawei Technologies is exploring new markets in the Middle East and Southeast...
LONDON/NEW YORK CITY: American grocery bills may be headed higher as coffee and orange juice prices face upward pressure from new tariffs...
BATTLE CREEK, Michigan: In a major consolidation of iconic food brands, WK Kellogg has agreed to be acquired by the owner of Ferrero...
WASHINGTON, D.C.: Filmmaker Peter Jackson's lifelong fascination with the extinct giant New Zealand flightless bird called the moa...
NEW DELHI, India: India has submitted a revised proposal to the World Trade Organization (WTO) in Geneva to implement retaliatory tariffs...